ILF3 and viral infectious disease: Given the widespread impact of the binding of NF90 to RNAs during homeostasis, viral infection, and cancer progression, it would be tempting to envision the application of this knowledge for the development of therapeutics designed in order to inhibit or promote NF90 binding to selected RNAs.